Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100052235Phase 4Recruiting
Phase 4, open-label trial of remimazolam and esketamine in Gastroesophageal varices (GEV) (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Number of rescue cases and total rescue drug amount. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100052235.